The topic of Phenprobamate is one that has captured the attention of many people in recent years. Since its emergence, Phenprobamate has generated a continuous debate in different sectors of society, whether in the academic, political, economic or cultural spheres. Opinions regarding Phenprobamate vary greatly, and its impact has become evident in various spheres. In this article, we will explore various perspectives on Phenprobamate and its influence today, as well as its historical relevance. Additionally, we will analyze the role that Phenprobamate plays in people's daily lives and in society as a whole.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 5–8 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.010.552 |
Chemical and physical data | |
Formula | C10H13NO2 |
Molar mass | 179.219 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Phenprobamate (Gamaquil, Isotonil, Actozine) is a centrally acting skeletal muscle relaxant, with additional sedative and anticonvulsant effects.[unreliable source?] Overdose is similar to barbiturates. Its mechanism of action is probably similar to meprobamate. Phenprobamate has been used in humans as an anxiolytic, and is still sometimes used in general anesthesia and for treating muscle cramps and spasticity. Phenprobamate is still used in some European countries, but it has generally been replaced by newer drugs. Phenprobamate is metabolized by oxidative degradation of the carbamate group and ortho-hydroxylation of the benzene ring, and is eliminated in urine by the kidneys.[citation needed]
Doses range from 400 to 800 mg, up to 3 times a day.